Neuroscience Antibodies & Assays Global Market Report 2022: Ukraine-Russia War Impact

NEW YORK, Dec. 9, 2022 /PRNewswire/ -- Major players in the neuroscience antibodies & assays market are Abcam PLC, BioLegend Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, GenScript Biotech Corporation, Merck KgaA, Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Siemens Healthineers, Tecan Group Ltd., Thermo Fisher Scientific Inc., and Enzo Life Sciences AG.



Read the full report: https://www.reportlinker.com/p06371387/?utm_source=PRN



The global neuroscience antibodies & assays market is expected to grow from $3.22 billion in 2021 to $3.58 billion in 2022 at a compound annual growth rate (CAGR) of 11.21%.The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, effecting many markets across the globe. The neuroscience antibodies & assays market is expected to reach $5.43 billion in 2026 at a compound annual growth rate (CAGR) of 10.97%.

The neuroscience antibodies & assays market consists of sales of neuroscience antibodies & assays by entities (organizations, sole traders, and partnerships) that are used to study the development, systems, structure and function, disorders, and degeneration of the nervous system.Neuroscience is the study of the nervous system, its working, and diseases related to the nervous system.

Antibodies and assays is a medical test that is based on principles of interaction between antigenic epitopes and antibodies, and this test is useful in neuroscience and the study of neurological disorders.

The main types of neuroscience antibodies & assays market products are consumables, and instruments.Consumables are used in many neurological studies and research experiments.

Consumable includes assay kits, reagents, and antibodies that enable quantitative and real-time live-cell analysis.The technologies used are molecular diagnostics, clinical chemistry, immunoassays or immunochemistry, and others technologies.

The various applications are in vitro diagnostics, research, and drug discovery. The various end users are hospitals and diagnostics centers, academic and research institutes, pharmaceutical and biotechnology companies.

North America was the largest region in the neuroscience antibodies & assays market in 2021. The regions covered in neuroscience antibodies & assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The increasing incidents of neurological illnesses across the globe are expected to propel the growth of the neuroscience antibodies & assays market going forward.Neurological illnesses are disorders affecting the nervous system and examples of neurological disorders include epilepsy, alzheimer's disease, dementia and so on.

The rise in the number of neurological illnesses requires more research and development activities for the treatment of these diseases.Antibodies and assays are used in research and development activities to study development, systems, structure and function, and disorders and degeneration of the nervous system.

Thus, the neuroscience antibodies & assays market grows with the increase in incidents of neurological illnesses.For instance, According to World Health Organization, a Switzerland-based health promotion agency 55 million people live with dementia globally, and there are nearly 10 million new cases every year as per 2021 data.

According to Alzheimer's Association a US based Non-profit association, 6.5 million people in the US have Alzheimer's disease as per 2022 data. As a result, the increased incidence of neurological illnesses across the world is driving the neuroscience antibodies and assays market forward.

Technological advancements are a key trend gaining popularity in the neuroscience antibodies and assays market.Major companies operating in the market are introducing new technologies such as Cisbio HTRF® that works on TR-FRET technology to sustain their position in the market.

For instance, in October 2020, PerkinElmer Inc, a US-based diagnostics, life sciences, and environmental research company, launched "PerkinElmer Cisbio HTRF® Phospho-Ubiquitin (Ser65) Cellular Kit".The new kit has applications in various disease areas such as Alzheimer's and Parkinson's disease.

The novel assay's can be applied to increase study specificity for the Phospho-Ubiquitin (Ser65) intersection point. With the help of TR-FRET technology helps to identify crucial mitophagy dysfunction and breakdowns in the intricate network between neurons and glial cells that can result in neurodegenerative disease.

In June 2022, Fujirebio, a Japanese multinational biotechnology company, acquired ADx NeuroSciences for an undisclosed amount.With this acquisition, Fujirebio will be able to provide neurodegenerative disease diagnostic solutions at the global level.

ADx Neurosciences is a Belgium-based developer of neurodegenerative biomarkers and specialized in developing tailor-made antibodies and assays for pharma and in vitro diagnostics companies.

The countries covered in the neuroscience antibodies & assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The neuroscience antibodies & assays market research report is one of a series of new reports that provides neuroscience antibodies & assays market statistics, including neuroscience antibodies & assays industry global market size, regional shares, competitors with an neuroscience antibodies & assays market share, detailed neuroscience antibodies & assays market segments, market trends and opportunities, and any further data you may need to thrive in the neuroscience antibodies & assays industry. This neuroscience antibodies & assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Read the full report: https://www.reportlinker.com/p06371387/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.



Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

Cision
Cision

View original content:https://www.prnewswire.com/news-releases/neuroscience-antibodies--assays-global-market-report-2022-ukraine-russia-war-impact-301698191.html

SOURCE Reportlinker